Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA)
A Multicenter, Open Label, Prospective, Randomized Study of the MynxGrip Vascular Closure Device in Subjects With Diagnostic or Interventional Endovascular Procedures (PANDA Study)
Sponsor: Cardinal Health
Listed as NCT03923387, this NA trial focuses on Endovascular and remains completed. Sponsored by Cardinal Health, it has been updated 9 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Dec 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Dec 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jul 2022 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2021 — Jul 2022 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
-
Feb 2020 — Sep 2020 [monthly]
Recruiting NA
-
Jul 2019 — Feb 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2019 — Jul 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cardinal Health
- Cordis US Corp.
For direct contact, visit the study record on ClinicalTrials.gov .